Dr. Rasheed Balogun, M.D.
Nephrology (Kidney) (Nephrology Physician)
- Medicare participating
At a glance
- Years since graduation
- 35
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 360
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
VA license 0101231690
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Virginia Medical Center Charlottesville, VA
- Uva Health Culpeper Medical Center Culpeper, VA
Medical groups
- University of Virginia Physicians Group (1,717 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 360
- Services billed
- 873
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 188 | 142 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 118 | 65 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 101 | 22 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 88 | 52 |
| Hemodialysis procedure with physician evaluation | 80 | 40 |
| Established patient office or other outpatient visit, 20-29 minutes | 44 | 37 |
| Dialysis procedure including 1 evaluation | 38 | 19 |
| New patient office or other outpatient visit, 45-59 minutes | 35 | 35 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 28 | 15 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 24 | 22 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Jardiance (empagliflozin) Other prescribers in Charlottesville, VA | 90 |
| Amlodipine Besylate Other prescribers in Charlottesville, VA | 56 |
| Losartan Potassium Other prescribers in Charlottesville, VA | 54 |
| Hydrochlorothiazide Other prescribers in Charlottesville, VA | 52 |
| Calcitriol Other prescribers in Charlottesville, VA | 50 |
| Lisinopril Other prescribers in Charlottesville, VA | 42 |
| Allopurinol Other prescribers in Charlottesville, VA | 29 |
| Clonidine Other prescribers in Charlottesville, VA | 19 |
| Furosemide Other prescribers in Charlottesville, VA | 16 |
| Thiola Ec (tiopronin) | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 4 payments worth $12,447 in total to this clinician.
| Nipro Medical Corporation | $12,255 |
|---|---|
| Alexion Pharmaceuticals, Inc. | $109 |
| Vertex Pharmaceuticals Incorporated | $83.08 |
| Compensation for services other than consulting (speaking, faculty) | $12,255 |
|---|---|
| Food and Beverage | $192 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Nipro Medical Corporation Nov 18, 2025 | Compensation for services other than consulting (speaking, faculty) Hemodialysis System · Device | $6,856 |
| Nipro Medical Corporation Nov 18, 2025 | Compensation for services other than consulting (speaking, faculty) Hemodialysis System · Device | $5,399 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $29,167 in research payments for these studies, mostly to the institutions running them.
- A Phase 2/3 Adaptive, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Subjects Aged 18 Years and Older With APOL1-mediated Proteinuric Kidney Disease
Vertex Pharmaceuticals Incorporated - A Study of the Prevalance of Apolipoprotein L1 (APOL1) Alleles Among Individuals With Proteinuric Kidney Disease Who Are of Recent African Ancestry or Geographic Origin
Vertex Pharmaceuticals Incorporated
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.